Study on the material basis of Zhujing pill in treating fundus lesions through component analysis and network pharmacology

Abstract Zhujing pill (ZP) is a famous Chinese herbal formula that has been widely used to treat diabetic retinopathy, macular degeneration, retinitis pigmentosa and other fundus lesions. In this study, the material basis and mechanism of ZP in the treatment of fundus lesions were evaluated via the high‐performance liquid chromatography fingerprint, ultra‐performance liquid chromatography quadrupole time‐of‐flight mass spectrometry, network pharmacology and molecular docking. A total of 32 common components were found and 31 components were identified in 15 batches of ZP samples. Moreover, 134 common key targets and 17 putative active components that are connected to fundus lesions were identified. Molecular docking revealed that quercetin, kaempferol, isorhamnetin, 5‐ O ‐feruloylquinic acid, plantagoside and 2′‐acetylacteoside have the ability to interact with the core targets such as AKT1, TP53, TNF, IL‐6 and Jun. Our findings revealed that the therapeutic effects of ZP on fundus lesions are mediated by multiple components, targets and pathways, including at least six active ingredients and 11 targets. The study provides new ideas for further research on the material basis and mechanisms of traditional Chinese medicine prescriptions.